4//SEC Filing
Tak Paul Peter 4
Accession 0001209191-23-026581
CIK 0001841387other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:10 PM ET
Size
6.4 KB
Accession
0001209191-23-026581
Insider Transaction Report
Form 4
Tak Paul Peter
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-04-28+180,000→ 180,000 totalExercise: $1.29Exp: 2033-04-28→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]One third of the shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date. One third of the shares underlying this option shall vest and become exercisable if the average closing market price of the Issuer's common stock exceeds $3.00 per share for at least 20 consecutive trading days prior to the expiration of the option. The final third of shares underlying this option shall vest and become exercisable if the average closing market price of the Issuer's common stock exceeds $4.50 per share for at least 20 consecutive trading days prior to the expiration of the option. If either stock price hurdle is achieved prior to April 28, 2024, the applicable award would vest fully on April 28, 2024, so long as the Reporting Person remains an employee or service provider of the Issuer through such date.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873905
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 5:10 PM ET
- Size
- 6.4 KB